Behçet's disease with life-threatening haemoptoe and pulmonary aneurysms: Complete remission after infliximab treatment [3]

Annals of the Rheumatic Diseases

Volumn 65, Issue 11, 2006, Pages 1531-1532

  Baki, K ^a   Villiger, P M ^b   Jenni, D ^a   Meyer, T ^a   Beer, J H ^a  

^a Kantonsspital Baden   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; COLCHICINE; INFLIXIMAB; PREDNISONE; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ADULT; ANAMNESIS; ANEURYSM; BEHCET DISEASE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENDOCARDITIS; HEMOPTYSIS; HUMAN; LABORATORY TEST; LETTER; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; METHODOLOGY; PULMONARY ARTERY;

ADULT; ANEURYSM; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; HEMOPTYSIS; HUMANS; MALE; PULMONARY ARTERY; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750299006     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.045195     Document Type: Letter

References (6)

1. Hamuryudan V, Er T, Seyahi E, et al. Pulmonary artery aneurysms in Behçet syndrome. Am J Med 2004;117:867-70.
2. Yazici H. Behçet's syndrome: where do we stand? Am J Med 2002;112:75-6.
3. Saba D, Saricaoglu H, Bayram AS, et al. Arterial lesions in Behçet's disease. Vasa 2003;32:75-81.
4. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
5. Sfikakis P. Behçet's disease: a new target for anti-tumor necrosis factor treatment. Ann Rheum Dis 2002;61:51-3.
6. Aeberli D, Oertle S, Mauron H, et al. Inhibition of the TNF-pathway: use of infliximab and entanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. Swiss Med Wkly 2002;123:414-22.